NTR ApS: Financial statements 2022
CVR: 41551070
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NTR ApS (CVR 41551070) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 5,070,775 and a net result of DKK 1,417,272. Equity in the 2022 report amounted to DKK 917,184. The solvency ratio was 50.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 5,070,775
- Profit/Loss
- DKK 1,417,272
- Equity
- DKK 917,184
- Total Assets
- DKK 1,805,936
- Employees
- 2
Official annual report
Keep an eye on NTR ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of June 25, 2022, Diagnostix Holding ApS is registered as an owner of NTR ApS with an ownership share of 33%.
NTR ApS has published its interim report for the period July 28, 2020 – December 31, 2021.
As of February 1, 2022, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of NTR ApS.
About NTR ApS
NTR ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company is registered under the industry Aktiviteter inden for hospitalsvæsen. The management consists of Robert Gabriel Coumine Riis and Thomas Frese Hasseriis. The company is owned by Diagnostix Holding ApS, Riis Medical Consulting ApS and TFH Medical Consulting ApS. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 3,593,373 and a net result of DKK 1,190,585 compared with DKK 1,804,834 the year before. Equity in the 2025 report amounted to DKK 1,439,136.